352 related articles for article (PubMed ID: 25843618)
1. Innate immune evasion by filoviruses.
Basler CF
Virology; 2015 May; 479-480():122-30. PubMed ID: 25843618
[TBL] [Abstract][Full Text] [Related]
2. Innate Immune Responses of Bat and Human Cells to Filoviruses: Commonalities and Distinctions.
Kuzmin IV; Schwarz TM; Ilinykh PA; Jordan I; Ksiazek TG; Sachidanandam R; Basler CF; Bukreyev A
J Virol; 2017 Apr; 91(8):. PubMed ID: 28122983
[TBL] [Abstract][Full Text] [Related]
3. Filoviral immune evasion mechanisms.
Ramanan P; Shabman RS; Brown CS; Amarasinghe GK; Basler CF; Leung DW
Viruses; 2011 Sep; 3(9):1634-49. PubMed ID: 21994800
[TBL] [Abstract][Full Text] [Related]
4. The role of antigen-presenting cells in filoviral hemorrhagic fever: gaps in current knowledge.
Martinez O; Leung LW; Basler CF
Antiviral Res; 2012 Mar; 93(3):416-28. PubMed ID: 22333482
[TBL] [Abstract][Full Text] [Related]
5. Evasion of interferon responses by Ebola and Marburg viruses.
Basler CF; Amarasinghe GK
J Interferon Cytokine Res; 2009 Sep; 29(9):511-20. PubMed ID: 19694547
[TBL] [Abstract][Full Text] [Related]
6. Effects of Filovirus Interferon Antagonists on Responses of Human Monocyte-Derived Dendritic Cells to RNA Virus Infection.
Yen BC; Basler CF
J Virol; 2016 May; 90(10):5108-5118. PubMed ID: 26962215
[TBL] [Abstract][Full Text] [Related]
7. Novel activities by ebolavirus and marburgvirus interferon antagonists revealed using a standardized in vitro reporter system.
Guito JC; Albariño CG; Chakrabarti AK; Towner JS
Virology; 2017 Jan; 501():147-165. PubMed ID: 27930961
[TBL] [Abstract][Full Text] [Related]
8. Differential Regulation of Interferon Responses by Ebola and Marburg Virus VP35 Proteins.
Edwards MR; Liu G; Mire CE; Sureshchandra S; Luthra P; Yen B; Shabman RS; Leung DW; Messaoudi I; Geisbert TW; Amarasinghe GK; Basler CF
Cell Rep; 2016 Feb; 14(7):1632-1640. PubMed ID: 26876165
[TBL] [Abstract][Full Text] [Related]
9. Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses.
Martines RB; Ng DL; Greer PW; Rollin PE; Zaki SR
J Pathol; 2015 Jan; 235(2):153-74. PubMed ID: 25297522
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for Marburg virus VP35-mediated immune evasion mechanisms.
Ramanan P; Edwards MR; Shabman RS; Leung DW; Endlich-Frazier AC; Borek DM; Otwinowski Z; Liu G; Huh J; Basler CF; Amarasinghe GK
Proc Natl Acad Sci U S A; 2012 Dec; 109(50):20661-6. PubMed ID: 23185024
[TBL] [Abstract][Full Text] [Related]
11. Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus.
Messaoudi I; Amarasinghe GK; Basler CF
Nat Rev Microbiol; 2015 Nov; 13(11):663-76. PubMed ID: 26439085
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of filoviral haemorrhagic fevers.
Mahanty S; Bray M
Lancet Infect Dis; 2004 Aug; 4(8):487-98. PubMed ID: 15288821
[TBL] [Abstract][Full Text] [Related]
13. Broad and Temperature Independent Replication Potential of Filoviruses on Cells Derived From Old and New World Bat Species.
Miller MR; McMinn RJ; Misra V; Schountz T; Müller MA; Kurth A; Munster VJ
J Infect Dis; 2016 Oct; 214(suppl 3):S297-S302. PubMed ID: 27354372
[TBL] [Abstract][Full Text] [Related]
14. How Ebola and Marburg viruses battle the immune system.
Mohamadzadeh M; Chen L; Schmaljohn AL
Nat Rev Immunol; 2007 Jul; 7(7):556-67. PubMed ID: 17589545
[TBL] [Abstract][Full Text] [Related]
15. Topoisomerase II Inhibitors Induce DNA Damage-Dependent Interferon Responses Circumventing Ebola Virus Immune Evasion.
Luthra P; Aguirre S; Yen BC; Pietzsch CA; Sanchez-Aparicio MT; Tigabu B; Morlock LK; García-Sastre A; Leung DW; Williams NS; Fernandez-Sesma A; Bukreyev A; Basler CF
mBio; 2017 Apr; 8(2):. PubMed ID: 28377530
[TBL] [Abstract][Full Text] [Related]
16. Characterization of host immune responses in Ebola virus infections.
Wong G; Kobinger GP; Qiu X
Expert Rev Clin Immunol; 2014 Jun; 10(6):781-90. PubMed ID: 24742338
[TBL] [Abstract][Full Text] [Related]
17. Activation of triggering receptor expressed on myeloid cells-1 on human neutrophils by marburg and ebola viruses.
Mohamadzadeh M; Coberley SS; Olinger GG; Kalina WV; Ruthel G; Fuller CL; Swenson DL; Pratt WD; Kuhns DB; Schmaljohn AL
J Virol; 2006 Jul; 80(14):7235-44. PubMed ID: 16809329
[TBL] [Abstract][Full Text] [Related]
18. Role of EXT1 and Glycosaminoglycans in the Early Stage of Filovirus Entry.
O'Hearn A; Wang M; Cheng H; Lear-Rooney CM; Koning K; Rumschlag-Booms E; Varhegyi E; Olinger G; Rong L
J Virol; 2015 May; 89(10):5441-9. PubMed ID: 25741008
[TBL] [Abstract][Full Text] [Related]
19. Tyro3 family-mediated cell entry of Ebola and Marburg viruses.
Shimojima M; Takada A; Ebihara H; Neumann G; Fujioka K; Irimura T; Jones S; Feldmann H; Kawaoka Y
J Virol; 2006 Oct; 80(20):10109-16. PubMed ID: 17005688
[TBL] [Abstract][Full Text] [Related]
20. Immune evasion in ebolavirus infections.
Audet J; Kobinger GP
Viral Immunol; 2015 Feb; 28(1):10-8. PubMed ID: 25396298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
